Scope of new formulation approaches in the repurposing of pioglitazone for the management of Alzheimer’s disease
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Scope of new formulation approaches in the repurposing of pioglitazone for the management of Alzheimer’s disease
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-02-10
DOI
10.1111/jcpt.12808
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In Situ-Based Gels for Nose to Brain Delivery for the Treatment of Neurological Diseases
- (2018) Blessing Aderibigbe Pharmaceutics
- Pioglitazone ameliorates Aβ42 deposition in rats with diet-induced insulin resistance associated with AKT/GSK3β activation
- (2017) Sisi Yang et al. Molecular Medicine Reports
- Nose to brain transport pathways an overview: potential of nanostructured lipid carriers in nose to brain targeting
- (2017) Kousalya Selvaraj et al. Artificial Cells Nanomedicine and Biotechnology
- Mitochondrial Alterations, Oxidative Stress and Neuroinflammation in Alzheimer's Disease
- (2017) M. Verri et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Intranasal Insulin Administration Dose-Dependently Modulates Verbal Memory and Plasma Amyloid-β in Memory-Impaired Older Adults
- (2017) Mark A. Reger et al. JOURNAL OF ALZHEIMERS DISEASE
- An Integrated and Unifying Hypothesis for the Metabolic Basis of Sporadic Alzheimer's Disease
- (2017) Adnan Erol JOURNAL OF ALZHEIMERS DISEASE
- Insulin-degrading enzyme: new therapeutic target for diabetes and Alzheimer’s disease?
- (2016) Olga Pivovarova et al. ANNALS OF MEDICINE
- Drug-metabolizing Enzymes and Efflux Transporters in Nasal Epithelium: Influence on the Bioavailability of Intranasally Administered Drugs
- (2016) Paula Oliveira et al. CURRENT DRUG METABOLISM
- Nanoparticle-mediated brain drug delivery: Overcoming blood–brain barrier to treat neurodegenerative diseases
- (2016) Cláudia Saraiva et al. JOURNAL OF CONTROLLED RELEASE
- Pioglitazone use and risk of bladder cancer: population based cohort study
- (2016) Marco Tuccori et al. BMJ-British Medical Journal
- Pioglitazone use and risk of bladder cancer: population based cohort study
- (2016) Marco Tuccori et al. BMJ-British Medical Journal
- Current Research Therapeutic Strategies for Alzheimer’s Disease Treatment
- (2016) Jaume Folch et al. NEURAL PLASTICITY
- Novel GLP-1 (Glucagon-Like Peptide-1) Analogues and Insulin in the Treatment for Alzheimer’s Disease and Other Neurodegenerative Diseases
- (2015) Valeria Calsolaro et al. CNS DRUGS
- The Blood–Brain Barrier
- (2015) Richard Daneman et al. Cold Spring Harbor Perspectives in Biology
- Influence of drug transporters and stereoselectivity on the brain penetration of pioglitazone as a potential medicine against Alzheimer's disease
- (2015) Kai Lun Chang et al. Scientific Reports
- Anti-Diabetes Drug Pioglitazone Ameliorates Synaptic Defects in AD Transgenic Mice by Inhibiting Cyclin-Dependent Kinase5 Activity
- (2015) Jinan Chen et al. PLoS One
- Overcoming the Blood–Brain Barrier for Delivering Drugs into the Brain by Using Adenosine Receptor Nanoagonist
- (2014) Xihui Gao et al. ACS Nano
- Elevated risk of type 2 diabetes for development of Alzheimer disease: A key role for oxidative stress in brain
- (2014) D. Allan Butterfield et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Invokana (Canagliflozin) as a Dual Inhibitor of Acetylcholinesterase and Sodium Glucose Co-Transporter 2: Advancement in Alzheimer’s Disease- Diabetes Type 2 Linkage via an Enzoinformatics Study
- (2014) Syed Rizvi et al. CNS & Neurological Disorders-Drug Targets
- Alzheimer’s Disease and Type 2 Diabetes: Multiple Mechanisms Contribute to Interactions
- (2014) Anusha Jayaraman et al. Current Diabetes Reports
- Pioglitazone ameliorates memory deficits in streptozotocin-induced diabetic mice by reducing brain β-amyloid through PPARγ activation
- (2013) Li-ping Liu et al. ACTA PHARMACOLOGICA SINICA
- Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action
- (2013) Jonathan E. Campbell et al. Cell Metabolism
- Insights into direct nose to brain delivery: current status and future perspective
- (2013) Deepti Mittal et al. DRUG DELIVERY
- Curcumin loaded solid lipid nanoparticles: An efficient formulation approach for cerebral ischemic reperfusion injury in rats
- (2013) Vandita Kakkar et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Pioglitazone Ameliorates Intracerebral Insulin Resistance and Tau-protein Hyperphosphorylation in Rats with Type 2 Diabetes
- (2013) S.-H. Hu et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Development of a novel niosomal system for oral delivery of Ginkgo biloba extract
- (2013) Ye Jin et al. International Journal of Nanomedicine
- Comparative in vitro and in vivo evaluation of lipid based nanocarriers of Huperzine A
- (2013) Pratikkumar A. Patel et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Resveratrol-Loaded Lipid-Core Nanocapsules Treatment Reduces In Vitro and In Vivo Glioma Growth
- (2013) Fabrício Figueiró et al. Journal of Biomedical Nanotechnology
- Troglitazone, a thiazolidinedione, decreases tau phosphorylation through the inhibition of cyclin-dependent kinase 5 activity in SH-SY5Y neuroblastoma cells and primary neurons
- (2013) Du-Hyong Cho et al. JOURNAL OF NEUROCHEMISTRY
- Therapeutics of Alzheimer's disease: Past, present and future
- (2013) R. Anand et al. NEUROPHARMACOLOGY
- Pioglitazone Improves Cognitive Function via Increasing Insulin Sensitivity and Strengthening Antioxidant Defense System in Fructose-Drinking Insulin Resistance Rats
- (2013) Qing-Qing Yin et al. PLoS One
- Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?
- (2013) Matthias van Woensel et al. Cancers
- PPARγ Agonist Pioglitazone Reverses Memory Impairment and Biochemical Changes in a Mouse Model of Type 2 Diabetes Mellitus
- (2012) Li-Ying Jiang et al. CNS Neuroscience & Therapeutics
- Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic
- (2012) Anu Puri et al. CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS
- Altered APP Processing in Insulin-Resistant Conditions Is Mediated by Autophagosome Accumulation via the Inhibition of Mammalian Target of Rapamycin Pathway
- (2012) S. M. Son et al. DIABETES
- Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting
- (2012) Mohammad Fazil et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Development and evaluation of thymoquinone-encapsulated chitosan nanoparticles for nose-to-brain targeting: a pharmacoscintigraphic study
- (2012) Sanjar Alam et al. International Journal of Nanomedicine
- Drug Transport across the Blood–Brain Barrier
- (2012) William M Pardridge JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Preparation, characterization,in vivoand biochemical evaluation of brain targeted Piperine solid lipid nanoparticles in an experimentally induced Alzheimer’s disease model
- (2012) Mohammad Yusuf et al. JOURNAL OF DRUG TARGETING
- Metformin, Other Antidiabetic Drugs, and Risk of Alzheimer's Disease: A Population-Based Case-Control Study
- (2012) Patrick Imfeld et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Insulin resistance in the nervous system
- (2012) Bhumsoo Kim et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Apolipoprotein E, amyloid-ß clearance and therapeutic opportunities in Alzheimer's disease
- (2012) Adam Kline Alzheimers Research & Therapy
- Expression of Tight Junction and Drug Efflux Transporter Proteins in an in vitro Model of Human Blood–Brain Barrier
- (2012) Chiara Cioni et al. Frontiers in Psychiatry
- Advances in the pathogenesis of Alzheimer's disease: a re-evaluation of amyloid cascade hypothesis
- (2012) Dong Suzhen et al. Translational Neurodegeneration
- Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment
- (2011) Suzanne Craft ARCHIVES OF NEUROLOGY
- Brain Insulin Signaling and Alzheimer's Disease: Current Evidence and Future Directions
- (2011) Helgi B. Schiöth et al. MOLECULAR NEUROBIOLOGY
- S-Nitrosylation activates Cdk5 and contributes to synaptic spine loss induced by -amyloid peptide
- (2011) J. Qu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Randomized Pilot Clinical Trial of the Safety of Pioglitazone in Treatment of Patients With Alzheimer Disease
- (2010) David S. Geldmacher et al. ARCHIVES OF NEUROLOGY
- Pioglitazone improves lipid and insulin levels in overweight rats on a high cholesterol and fructose diet by decreasing hepatic inflammation
- (2010) Massimo Collino et al. BRITISH JOURNAL OF PHARMACOLOGY
- Rivastigmine-loaded PLGA and PBCA nanoparticles: Preparation, optimization, characterization, in vitro and pharmacodynamic studies
- (2010) Shrinidh A. Joshi et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain
- (2009) Zhao H. Wang et al. BIOMATERIALS
- Impact of OATP transporters on pharmacokinetics
- (2009) A Kalliokoski et al. BRITISH JOURNAL OF PHARMACOLOGY
- Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles
- (2009) Kamila B. Kurakhmaeva et al. JOURNAL OF DRUG TARGETING
- PIOGLITAZONE IMPROVED COGNITION IN A PILOT STUDY ON PATIENTS WITH ALZHEIMER'S DISEASE AND MILD COGNITIVE IMPAIRMENT WITH DIABETES MELLITUS
- (2009) Haruo Hanyu et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease
- (2009) Tomohiko Sato et al. NEUROBIOLOGY OF AGING
- A study of rivastigmine liposomes for delivery into the brain through intranasal route
- (2008) Karthik Arumugam et al. ACTA PHARMACEUTICA
- Intranasal Mucoadhesive Microemulsion of Tacrine to Improve Brain Targeting
- (2008) Viral V. Jogani et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- A look inside the diabetic brain: Contributors to diabetes-induced brain aging
- (2008) Shayna A. Wrighten et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease
- (2008) Leah R Hanson et al. BMC NEUROSCIENCE
- Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease
- (2008) Barnabas Wilson et al. BRAIN RESEARCH
- Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting
- (2008) Xiaomei Wang et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles
- (2008) B WILSON et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Cholinergic system during the progression of Alzheimer’s disease: therapeutic implications
- (2008) Elliott J Mufson et al. Expert Review of Neurotherapeutics
- Pioglitazone inhibition of lipopolysaccharide-induced nitric oxide synthase is associated with altered activity of p38 MAP kinase and PI3K/Akt
- (2008) Bin Xing et al. Journal of Neuroinflammation
- Anxiety and cognitive effects of quercetin liposomes in rats
- (2008) Aroonsri Priprem et al. Nanomedicine-Nanotechnology Biology and Medicine
- PPARγ agonists as therapeutics for the treatment of Alzheimer’s disease
- (2008) Gary Landreth et al. Neurotherapeutics
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now